Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Tissue Engineered Cartilage for Articular Cartilage Repair
NCT02770209Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Feb 2012
- Primary completion
- Aug 2013
- Modality
- Bone Marrow HSCs, Peripheral Blood HSCs
01
Overview
Randomised, open-label trial of autologous cultured chondrocytes in articular cartilage injury, sponsored by Chinese PLA General Hospital. Primary endpoint: Magnetic resonance imaging at 18 months. Status: unknown.
02
Drugs
autologous cultured chondrocytes
03
Conditions
articular cartilage injury
Beyond the preview
Go deeper on NCT02770209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02770209.